about
Generalized Scaling and the Master Variable for Brownian Magnetic Nanoparticle Dynamics.Mixed Brownian alignment and Néel rotations in superparamagnetic iron oxide nanoparticle suspensions driven by an ac fieldApproaches for modeling magnetic nanoparticle dynamics.Molecular sensing with magnetic nanoparticles using magnetic spectroscopy of nanoparticle Brownian motion.Nonlinear simulations to optimize magnetic nanoparticle hyperthermia.SU-E-I-81: Toward in Vivo Magnetic Spectroscopy of Brownian Motion.Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.Temperature of the magnetic nanoparticle microenvironment: estimation from relaxation timesAnti-proliferative therapy for HIV cure: a compound interest approach.Comparisons of characteristic timescales and approximate models for Brownian magnetic nanoparticle rotations.Quantification of magnetic nanoparticles with low frequency magnetic fields: compensating for relaxation effectsMagnetic nanoparticle sensing: decoupling the magnetization from the excitation field.Simulations of magnetic nanoparticle Brownian motionToward Localized In Vivo Biomarker Concentration Measurements.Combined Néel and Brown rotational Langevin dynamics in magnetic particle imaging, sensing, and therapy.Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.Model-based estimation of superinfection prevalence from limited datasets.Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials.A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferationAnti-proliferative therapy for HIV cure: a compound interest approachTH-A-WAB-01: Biomarker SensingTU-G-217A-07: Magnetic Nanoparticle Quantitation: Compensating for Relaxation EffectsDynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan womenMolecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trialsA SARS-CoV-2 vaccine candidate would likely match all currently circulating strainsReliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
P50
Q35951087-0BA75EC0-C108-4C5A-ABCE-7D61A3B8EE91Q36198999-74C5BCA9-E19D-45CE-8795-903502FCF7AEQ38255791-DEE4F422-2C52-4A69-B298-0A786417DA90Q38313792-85F63219-E329-4C9F-BC67-329A8FD605A1Q38634265-ABB9CC58-DD6C-43BB-B13A-A8073E5A6FD3Q38778335-EB1A3F81-5C56-4363-84A6-4B4FA9FBD1D3Q38839394-2F49D69B-E991-41C6-B0E8-43426B5FF607Q39629549-6B5235AD-BB50-4F1C-9D78-C44EEA4F9382Q40150493-661C2C4B-CA2C-428E-B37E-7F62523C5337Q40779723-D6DE5248-AB5B-45BE-8333-1980CC14DD63Q41822851-08D0C119-9DD9-4779-BD32-C93453888EC1Q41987960-0B20CFC1-B086-45B3-B7D4-441E5A4053EAQ42094288-DE5FD5AF-4931-46BB-A536-13463F3D644DQ42358894-DBDF47FA-6953-4BC9-9CE6-483152967527Q43142724-DE93B376-559E-4D0B-8198-E860B65A2AE8Q47184537-00FB7656-F71A-429E-8ACC-B51DFD7828A8Q50533686-C253A695-A21C-4A4F-89F4-89B2F005C9C5Q54230395-1B8AF62B-BACF-404C-8B40-F4A536CE1C2DQ59136614-29D9CEB5-E693-4E3B-98E4-D1137CEC7DA1Q60944552-3EF0E053-4B9B-4147-A146-CE9CB1184CDAQ60944575-7373F326-E51F-44A6-859B-1D821DFAD634Q60944584-6A569C1F-4A71-43AC-857B-66CB778CB324Q89548066-C39D5B1D-B7A2-4EDA-81DE-3E2587CF530EQ89575126-2EE18642-6DA5-44AE-B0D0-A9A40DA8D6E3Q89830547-CD975E81-F578-4EFA-92DF-23784253B95BQ95601265-4797D10E-6E8B-4507-9BF4-F0F31EB42EEEQ95605576-39EC668E-2C12-4408-A5FA-2EF6026DCA51
P50
description
researcher, ORCID id # 0000-0001-5684-9538
@en
wetenschapper
@nl
name
Daniel Reeves
@ast
Daniel Reeves
@en
Daniel Reeves
@es
Daniel Reeves
@nl
type
label
Daniel Reeves
@ast
Daniel Reeves
@en
Daniel Reeves
@es
Daniel Reeves
@nl
prefLabel
Daniel Reeves
@ast
Daniel Reeves
@en
Daniel Reeves
@es
Daniel Reeves
@nl
P106
P1153
55750361500
P21
P31
P496
0000-0001-5684-9538